Asensus Surgical, Inc. (NYSE: ASXC), relating to its proposed merger with KARL STORZ Endoscopy-America, Inc., a wholly owned direct subsidiary of KARL STORZ SE & Co. KG. Under the terms of the agreement, KARL STORZ Endoscopy-America, Inc., and Karl Storz California Inc. will acquire each outstanding share of Asensus Surgical stock for $0.35 in cash, without interest.